CANDICE BITTINGER: Open Payments
NPI 1962857300 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,645 in 123 payments from 40 companies in 2025. Trend: 2023 $1,351 · 2024 $989 · 2025 $2,645
Food & beverage: $2,645
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $261 |
| GlaxoSmithKline, LLC. | 15 | $216 |
| PFIZER INC. | 9 | $181 |
| Daiichi Sankyo Inc. | 14 | $163 |
| Incyte Corporation | 6 | $149 |
| AstraZeneca Pharmaceuticals LP | 5 | $148 |
| Merck Sharp & Dohme LLC | 7 | $143 |
| BeOne Medicines USA, Inc. | 5 | $118 |
| Kite Pharma, Inc. | 1 | $117 |
| Janssen Biotech, Inc. | 5 | $112 |
Products named: JEMPERLI, KISQALI, KEYTRUDA, Yescarta, REBLOZYL, JAKAFI, BRUKINSA, TAGRISSO.
Industry payments across VA — which companies pay providers there.
